L-759,633
![]() | |
Systematic (IUPAC) name | |
---|---|
(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene | |
Identifiers | |
PubChem | CID 5311215 |
IUPHAR/BPS | 748 |
ChemSpider |
4470734 ![]() |
ChEMBL |
CHEMBL57367 ![]() |
Chemical data | |
Formula | C26H40O2 |
Molar mass | 384.593 g/mol |
| |
| |
![]() ![]() |
L-759,633 is an analgesic drug that is a cannabinoid agonist. It is a fairly selective agonist for the CB2 receptor, with selectivity of 163x for CB2 over CB1.[1]
It produces some similar effects to other cannabinoid agonists such as analgesia, but with little or no sedative or psychoactive effects due to its weak CB1 activity, and a relatively strong antiinflammatory effect due to its strong activity at CB2.[2][3]
See also
References
- ↑ Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG (1999). "Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630". British Journal of Pharmacology 126 (3): 665–72. doi:10.1038/sj.bjp.0702351. PMC 1565857. PMID 10188977.
- ↑ Huffman JW (2000). "The search for selective ligands for the CB2 receptor". Current pharmaceutical design 6 (13): 1323–37. doi:10.2174/1381612003399347. PMID 10903395.
- ↑ Huffman JW (2005). "CB2 receptor ligands". Mini reviews in medicinal chemistry 5 (7): 641–9. doi:10.2174/1389557054368844. PMID 16026310.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.